C.W.J. Starrenburg

Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath ‘in the bag’ as T-cell depletion: the Leiden experience

R M Y Barge, C.W.J. Starrenburg, JH Falkenburg et al. · Bone Marrow Transplantation · 2006 · 57 citations

Cell Therapy, Transplantation, Marrow Transplantation +12

Minimal GVHD following in-vitro Tcell–depleted allogeneic stem cell transplantation with reduced-intensity conditioning allowing subsequent infusions of donor lymphocytes in patients with hematological malignancies and solid tumors

Renée M. Y. Barge, Susanne Osanto, W.A.F.Erik Marijt et al. · Experimental Hematology · 2003 · 47 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +12

α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease

Eduardus F. M. Posthuma, Erik W.A. Marijt, Renée M. Y. Barge et al. · Biology of Blood and Marrow Transplantation · 2004 · 47 citations · Full text

High-dose Ara-C for remission induction and consolidation of previously untreated adults with ALL or lymphoblastic lymphoma

Roel Willemze, J. M. J. M. Zijlmans, G. J. den Ottolander et al. · Annals of Hematology · 1995 · 22 citations

High-dose Ara-c, Lymphoid Neoplasia, Hematological Malignancy +7

Deoxycytidine kinase, thymidine kinase and cytidine deaminase and the formation of ARA-CTP in leukemic cells in different phases of the cell cycle

D. J. Richel, L. P. Colly, M. W. Arentsen-Honders et al. · Leukemia Research · 1990 · 15 citations

Chromatin, Deoxycytidine Kinase, Cell Regulation +7